CLOV vs TDG · rev $1.37B vs P/E 41, rev $8.83B
Clover Health Investments Corp (CLOV) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. Revenue was up 11.2% from 2024-09-30 to 2025-09-30. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
CLOV currently screens at market cap $1.55B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the CLOV and TDG stock pages for the full models.
Not investment advice.